MedCity News

MedCity FemFwd: ACOG’s New Guidelines Around Endometriosis

WHOOP Secures $575M, Reaches $10B Valuation

WHOOP'S Series G round was led by Collaborative Fund and includes participation from 2PointZero Group, Qatar Investment Authority, Cristiano Ronaldo and LeBron James.

By Marissa Plescia

BioPharma, Pharma

Eli Lilly Gets Speedy FDA Nod for Oral GLP-1 Drug, a Competitor to New Novo Nordisk Pill

FDA approval for Eli Lilly’s oral GLP-1 drug, Foundayo, comes about three months after Novo Nordisk launched its Wegovy pill. While clinical trial results for both daily pills showed comparable weight reduction, Lilly’s pill offers patients a slight dosing advantage.

By Frank Vinluan

Health Tech, Providers

Dentist examining young patient woman teeth at dentist's office

From Cavities to Chronic Disease: Why Medicine and Dentistry Can’t Operate Separately

Untreated dental problems are driving millions of Americans to emergency rooms each year, costing the country billions and worsening chronic health conditions. Experts say bridging the historic divide between medical and dental care — through data connectivity, integrated health centers and AI-driven tools — could improve patient outcomes and reduce healthcare spending.

By Katie Adams

Latest Video

Latest News

MedCity Influencers

Fixing Healthcare Means Trusting Doctors and Patients — Not Payers

Legacy payers have had decades to readjust their approach. Costs continue to climb, patients still face denials, and physicians remain mired in bureaucracy. It’s time to replace a system built on restrictions with one built on trust — trust in clinicians to practice medicine and in patients to make informed choices.

By Peter J. Pronovost and Patrick Quigley

MedCity Influencers

Two surgeons and an instrument technician in an operating room perform reconstructive surgery.

The Digital Imperative: Why the Future of Surgery Will Be Built on Integrated Intelligence, Not More Devices

The future of surgery will be shaped less by what our tools can do than by how well our systems help humans think when it matters most. The question is no longer whether the OR will evolve. It’s who will lead the transition

By Ed Chekan

BioPharma, Startups, Health Tech, Payers, Providers

Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs

March has seen a slew of executive hires, exits and layoffs across the healthcare industry. For instance, Flare Capital Partners, SCAN Group and Advocate Health named new executives. There were also layoffs at organizations including Oracle, Takeda and Blue Shield of California.

By Katie Adams

Health Tech

Digital generated image of multi layered dollar sign making swirl pattern.

Jimini Health Raises $17M to Scale Clinician-Supervised AI for Behavioral Health

Jimini's $17 million round was from M13, Town Hall Ventures, LionBird, Zetta Venture Partners and OneMind.

By Marissa Plescia

BioPharma, Pharma

Eli Lilly’s Neuro Prospects Expand to Sleep Science With $6.3B Centessa Acquisition

Centessa Pharmaceuticals’ cleminorexton is part of the orexin agonist drug class, which could introduce a new approach to the treatment of narcolepsy and other sleep disorders. Acquiring Centessa brings Eli Lilly into a group of clinical-stage orexin agonist drug developers that includes Takeda Pharmaceutical, Alkermes, and Eisai.

By Frank Vinluan

Beyond Analytics: How Sellers Dorsey is Hard-Coding Value into Medicaid Policy [Video]

How to turn analytics into actual policy outcomes.

By Sellers Dorsey and MedCity News

MedCity Influencers

Healthcare Staff can Maximize the Value of AI with High Performing Endpoints

Whether AI-driven or legacy applications, the endpoint is the decisive moment. As AI increases in use, having hardware and software that supports a high-performance experience for all staff will improve operational efficiency, patient outcomes, and revenue.

By Kevin Greenway

MedCity Influencers

Concussion Protocols: What Providers Should Know to Diagnose, Treat, and Rehabilitate

Here are five things providers should know about concussions.

By Dr. Al Cobb

The Mechanics of a More Connected Healthcare Ecosystem [Video]

Arbiter’s Anjali Jameson on hospital and payer alignment.

By Arbiter and MedCity News

Artificial Intelligence, Hospitals, Providers

How Mass General Brigham Decides Which AI Tools Are Worth Scaling

Mass General Brigham evaluates AI tools by carefully monitoring real-world performance before scaling them system-wide. At HIMSS earlier this month, Rebecca Mishuris, the health system’s chief health information officer and vice president of digital, explained what this process looks like.

By Katie Adams

Payers

State Mitigation Strategies Could Blunt Medicaid Coverage Losses

An Urban Institute report finds that the One Big Beautiful Bill Act could cause 5–10 million people to lose Medicaid coverage by 2028, with outcomes heavily dependent on how states implement work requirements and eligibility rules.

By Marissa Plescia

BioPharma, Pharma

Kailera Plans IPO for Obesity Drug That Could Top Lilly’s Zepbound

Kailera Therapeutics’ planned IPO will fund ongoing clinical development of a pipeline led by a drug that could rival Eli Lilly’s Zepbound in both efficacy and tolerability. Meanwhile, Renaissance Capital’s recap of first quarter 2026 IPOs shows slowing activity amid market turbulence from tariffs and war.

By Frank Vinluan

BioPharma

MedCity Pivot Podcast: How Fujifilm Tackled An Existential Crisis

Fujifilm went from being the no. 1 camera film company to seeing sales tumble as consumers switched to digital cameras. Lars Petersen, CEO of the company's biotechnologies business, explains how the company pivoted to becoming a partner of the life sciences industry.

By Arundhati Parmar

MedCity Influencers

AI Is Fueling a New Arms Race in Healthcare: Here’s How We Stop It

Rather than using AI to compete, we must design AI to collaborate. As the regulatory landscape evolves and industry pledges push for real-time, electronic, and transparent authorizations, the imperative is clear: technology must bridge the payer-provider divide, not widen it.

By Matt Cunningham

MedCity Influencers

Red Light Therapy’s Regulatory Implications

For consumers and clinicians the difference between “FDA-cleared,” “FDA-registered,” and general wellness products is not always obvious. Clear communication about intended use and supporting evidence is essential for maintaining trust.

By Aman Kamasani